• ML216 BLM Helicase Inhibitor: Assay Workflows

  2026-08-26

  ML216 enables controlled interrogation of BLM-dependent DNA repair, from purified-helicase assays to genotype-matched cell proliferation and sister chromatid exchange studies. This guide connects biochemical potency with practical cancer-research workflows while distinguishing BLM-focused experiments from the WRN mechanism examined in the reference study.

• Filipin III for Reliable Membrane Cholesterol Assays

  2026-08-26

  This scenario-based guide explains how Filipin III, SKU B6034, can strengthen cholesterol detection in membranes alongside cell viability, proliferation, and cytotoxicity assays. It covers assay design, sample compatibility, handling, interpretation, and practical supplier selection without treating filipin fluorescence as a standalone measure of total cellular cholesterol.

• ABT-199 (Venetoclax) Workflow for Apoptosis Research

  2026-08-25

  Build more interpretable apoptosis and viability experiments with ABT-199, a highly selective BCL-2 probe for hematologic malignancy models. This workflow connects dose design, mitochondrial pathway readouts, and combination testing to practical troubleshooting insights from DLBCL research.

• VX-765: Translational Control of Pyroptosis

  2026-08-25

  A mechanistic and strategic guide to using VX-765 and its active metabolite VRT-043198 to distinguish caspase-1-driven cytokine maturation from broader inflammatory signaling and to strengthen translational pyroptosis studies.

• Cyclosporin A: Assays, Workflows, and Optimization

  2026-08-24

  Cyclosporin A enables controlled interrogation of calcineurin–NF-AT signaling, T-cell activation, and cyclophilin-dependent mitochondrial responses. This practical guide separates pharmacologic effects from genetic background, with executable assay parameters and troubleshooting strategies for reproducible immunology and cell biology workflows.

• Pseudo-UTP: A Strategic Lever for Better RNA

  2026-08-24

  A mechanistic and translational guide to using Pseudo-UTP as a design variable in RNA synthesis, mRNA vaccine development, and gene therapy research.

• Phosbind Acrylamide for Phosphorylation Analysis

  2026-08-23

  Phosbind Acrylamide adds a practical, antibody-independent layer to phosphorylation studies by converting phosphate-dependent binding into an SDS-PAGE mobility shift. It is especially useful for mapping treatment-responsive signaling changes, validating kinase or phosphatase activity, and testing phosphorylation hypotheses alongside apoptosis and phase-separation assays.

• TAI-1: From RB1 Organoids to Mitotic Assays

  2026-08-22

  TAI-1 is a potent Hec1 inhibitor whose mitotic mechanism can be studied in more informative, genotype-aware cancer models. This article connects RB1-deficient retinal organoid findings with practical assay design while distinguishing established evidence from testable hypotheses.

• Lisinopril Dihydrate: ACE Inhibitor Research Guide

  2026-08-22

  Lisinopril dihydrate is a water-soluble, long-acting ACE inhibitor used to modulate renin–angiotensin signaling in hypertension research and related cardiovascular and renal models. Its catalog-reported IC50 is 4.7 nM, while formulation, storage, and assay-specific exposure must be controlled independently.

• BCL9–β-Catenin Inhibition Restores PD-1 Response

  2026-08-21

  Feng et al. developed hydrocarbon-stapled peptides that disrupt the β-catenin–BCL9 interaction, suppress oncogenic Wnt transcription, and remodel the tumor immune microenvironment. In preclinical models, the lead peptide reduced regulatory T cells, increased dendritic-cell and cytotoxic T-cell activity, and sensitized tumors to PD-1 blockade, supporting a targeted strategy for overcoming immune checkpoint resistance.

• Arsenic, BBB Disruption, and MMP-2/MMP-9 in Mice

  2026-08-20

  The reference study links sodium arsenite exposure to cognitive impairment through MMP-2/MMP-9-associated blood–brain barrier disruption and hippocampal neuronal apoptosis. Its doxycycline intervention provides pharmacological evidence that preserving barrier integrity can mitigate arsenic-related behavioral and tissue injury, while also highlighting the limits of inferring causality from a single inhibitor.

• Sodium Nitroprusside in Sex-Informed Vascular Research

  2026-08-20

  Use Sodium Nitroprusside as an endothelium-independent nitric oxide donor to separate vascular smooth muscle responsiveness from systemic, autonomic, and sex-dependent drivers of hypertension. This practical guide connects telemetry-based angiotensin II models with vessel-ring and platelet workflows, including starting parameters and troubleshooting strategies.

• Minocycline HCl in Retinal Microglia Assays

  2026-08-19

  Minocycline HCl provides a practical pharmacological control for testing whether microglial activity is required for 40-Hz flicker–associated amyloid-β clearance. This workflow connects MHC-II profiling with Aβ assays, retinal function, formulation control, and troubleshooting for reproducible neuroinflammation studies.

• Dinaciclib and VHL Loss in Clear Cell Renal Cancer

  2026-08-19

  Nelson and colleagues identified a synthetic-lethal relationship between Dinaciclib treatment and VHL deficiency in clear cell renal cell carcinoma. Their combination of cell-based assays, mechanistic readouts, and an orthotopic patient-derived xenograft model supports selective targeting of both tumor bulk and CD105-defined cancer stem-cell populations, while highlighting important limits for clinical translation.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody in Osteogenesis

  2026-08-18

  Learn how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody can convert lithium-engineered exosomal Wnt10a biology into spatially resolved, reproducible fluorescence measurements. This guide focuses on assay architecture, controls, and interpretation across IHC, ICC, and flow cytometry.

3565 records 1/238 page Next 12345 下5页 Last page